Novel Approaches to Targeted Protein Degradation
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific disease-related proteins using cellular self-destruction mechanisms. As of now, over 20 targeted protein degraders have advanced into clinical development. WuXi AppTec has built a robust TPD discovery chemistry platform. We deliver synthetic and medicinal chemistry solutions for creating, identifying, and supporting the discovery of preclinical candidates. Curious to learn more? Watch the video below.
Related Content
The recent publication in the journal Organic Letters, 'DNA-Compatible Cyclization Reaction to Access 1,3,4-Oxadiazoles & 1,2,4-Triazoles' by our WuXi Biology...
VIEW RESOURCEIntroduction: Targeted Protein Degradation (TPD) has emerged as a promising therapeutic modality due to its potential to develop therapeutics for...
VIEW RESOURCE